Cargando…
Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
Interaction between epidermal growth factor receptor (EGFR) signaling with GM3 ganglioside expression has been previously described. However, little is known about EGFR and NeuGcGM3 co-expression in cancer patients and their therapeutic implications. In this paper, we evaluate the co-expression of E...
Autores principales: | Palomo, Addys González, Santana, Rancés Blanco, Pérez, Xiomara Escobar, Santana, Damián Blanco, Gabri, Mariano Rolando, Monzon, Kalet León, Pérez, Adriana Carr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035325/ https://www.ncbi.nlm.nih.gov/pubmed/27449755 http://dx.doi.org/10.1007/s10585-016-9811-0 |
Ejemplares similares
-
Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3
por: Palomo, Addys González, et al.
Publicado: (2018) -
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy
por: Uskent, Necdet, et al.
Publicado: (2020) -
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013) -
P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
por: Martínez, Darel, et al.
Publicado: (2012) -
Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis
por: Blanco, Rancés, et al.
Publicado: (2013)